Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 545, pseudogene (RNU6-545P) is a pseudogene representing a non-functional, processed copy of a U6 small nuclear RNA (snRNA) gene[1]. The U6 small nuclear RNA gene family encodes RNAs that are integral components of the spliceosome, a complex responsible for the removal of introns from pre-mRNA in eukaryotic cells[3][4]. However, as a pseudogene, RNU6-545P does not produce a functional RNA product and is not involved in cellular processes such as splicing[1]. There are multiple functional U6 snRNA genes in the human genome, but pseudogenes like RNU6-545P are generally transcriptionally inactive and do not serve as drug targets, biomarkers, or have any defined roles in disease or therapy[1][4]. Summary of findings: - This molecule is a non-coding RNA pseudogene, not a protein, enzyme, receptor, or other typical drug target[1]. - No evidence supports a biological, pathological, or therapy-related function for this pseudogene. - No drugs are known to interact with it, and it is not used as a biomarker or has relevant safety concerns. - It is not considered a therapeutic target in biomedical literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 545, pseudogene (RNU6-545P).